TAFINLAR (dabrafenib mesylate)
MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
GSK
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
MEKINIST (trametinib dimethyl sulfoxide)
MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
GSK
COTELLIC (cobimetinib fumarate)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+2
GENENTECH
MEKINIST (trametinib dimethyl sulfoxide)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
BRAFTOVI (encorafenib)
MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+3
ARRAY BIOPHARMA
MEKTOVI (binimetinib)
MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+2
ARRAY BIOPHARMA
BRAFTOVI (encorafenib)
ORAL TREATMENTS FOR NON-SMALL CELL LUNG CANCER · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+3
ARRAY/PFIZER
MEKTOVI (binimetinib)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+2
ARRAY/PFIZER
MEKINIST (trametinib dimethyl sulfoxide)
ANTINEOPLASTIC - MEK1 AND MEK2 KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals
TAFINLAR (dabrafenib mesylate)
ANTINEOPLASTIC - BRAF KINASE INHIBITORS · MALIGNANT MELANOMA WITH BRAF V600E MUTATION ·+5
Novartis Pharmaceuticals